Biopharma Insights

ConcertAI Unveils Next-Generation Clinical Trial Optimization Platform, CTO 2.0

ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced …

Continue ›››

Introducing “Lab-on-a-Molecule” Drug Discovery Approach via DNA Nanoswitches

The challenge faced by current compound screening approaches often lies in their limitations, either in throughput or their capacity to …

Continue ›››

Introducing PathExplore, a Game-Changing AI Tool for In-Depth Tumor Microenvironment Exploration

As we continue to make progress in oncology therapeutics, researchers are constantly seeking ways to improve patient outcomes by understanding …

Continue ›››

The Emergence of Diffusion Generative Models in Accelerating AI Drug Discovery

Recently, diffusion generative models, such as DALL-E 2 and Midjourney, have attracted considerable interest for their ability to create captivating …

Continue ›››

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

Researchers from MIT and the University of Massachusetts Medical School have developed a new type of lipid nanoparticle designed to …

Continue ›››

Top 10 Companies Shaping the Brain-Computer Interface Landscape: Invasive vs Non-Invasive BCI Technology

The brain-computer interface (BCI) technology domain is constantly progressing as researchers and companies collaborate to devise inventive solutions that connect …

Continue ›››

AI-Powered Peptide Discovery from Plant Sources Leads to a Breakthrough In Muscle Recovery

Nuritas, an innovator in AI-based peptide discovery from natural sources, has announced the results of a second clinical trial on …

Continue ›››

AbSci and Other AI-Powered Biotechs Lead the Way in Antibody Discovery

The monoclonal antibodies (mAbs) market has seen impressive growth in recent years, with the top-selling drugs increasingly being mAbs. The …

Continue ›››

QSimulate Launches Quantum Fingerprinting Product to Improve AI Drug Discovery

The field of drug discovery has witnessed a massive transformation in recent years, thanks to the integration of artificial intelligence …

Continue ›››

Gandeeva Therapeutics and Moderna Join Forces to Explore AI-Enabled Cryo-EM Technology

Gandeeva Therapeutics, a precision medicine company specializing in designing and developing novel therapeutics guided by cryogenic electron microscopy (cryo-EM) and …

Continue ›››

Portal Innovations Empowers Biotech Ventures in Chicago and Atlanta

Portal Innovations, headquartered in Chicago, is a biotech-focused venture capital company seeking to bolster the expansion of biotech startups in …

Continue ›››

MIMETAS' Recent Milestones in Advancing Drug Discovery Through Organ-on-a-Chip Technology

As the pharmaceutical industry seeks innovative solutions for preclinical development, organ-on-a-chip technology has gained significant traction in recent years. This …

Continue ›››